Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in TaxesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Capital Expenditures (2022 - 2025)

Historic Capital Expenditures for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$102844.1.

  • InflaRx's Capital Expenditures fell 546755.19% to -$102844.1 in Q3 2025 from the same period last year, while for Sep 2025 it was -$149105.3, marking a year-over-year decrease of 11205.62%. This contributed to the annual value of -$50730.3 for FY2024, which is 4186.22% up from last year.
  • Per InflaRx's latest filing, its Capital Expenditures stood at -$102844.1 for Q3 2025, which was down 546755.19% from -$17236.3 recorded in Q2 2025.
  • In the past 5 years, InflaRx's Capital Expenditures ranged from a high of -$1847.2 in Q3 2024 and a low of -$147408.4 during Q4 2022
  • Its 4-year average for Capital Expenditures is -$29054.3, with a median of -$17236.3 in 2025.
  • In the last 5 years, InflaRx's Capital Expenditures skyrocketed by 9202.18% in 2024 and then plummeted by 546755.19% in 2025.
  • InflaRx's Capital Expenditures (Quarter) stood at -$147408.4 in 2022, then soared by 74.34% to -$37827.9 in 2023, then soared by 52.32% to -$18036.8 in 2024, then tumbled by 470.19% to -$102844.1 in 2025.
  • Its Capital Expenditures was -$102844.1 in Q3 2025, compared to -$17236.3 in Q2 2025 and -$10988.0 in Q1 2025.